Eleanor S. Segal
Department of Global Drug Safety
Drug Regulatory Affairs and Biometry
Actelion Pharmaceuticals Ltd
Allschwil
Switzerland
Name/email consistency: medium
- Risk management strategies in the postmarketing period : safety experience with the US and European bosentan surveillance programmes. Segal, E.S., Valette, C., Oster, L., Bouley, L., Edfjall, C., Herrmann, P., Raineri, M., Kempff, M., Beacham, S., van Lierop, C. Drug. Saf (2005)